Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada: Structure, application and manufacturer responsibilities

PharmacoEconomics

Volumn 16, Issue 3, 1999, Pages 211-224

  Langley, Paul C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; HEALTH ECONOMICS; HEALTH INSURANCE; MANAGED CARE; NATIONAL HEALTH INSURANCE; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK MANAGEMENT;

BLUE CROSS; BLUE SHIELD; COLORADO; DRUG INDUSTRY; FORMULARIES, HOSPITAL; NEVADA;

EID: 0032855184     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916030-00001     Document Type: Review

References (12)

1. 1. Langley PC. Blue Cross and Blue Shield of Colorado, Guidelines for formulary submissions for pharmaceutical product evaluation. Denver (CO): Blue Cross and Blue Shield, 1998
2. 2. Rittenhouse B. Uses of models in economic evaluations of medicines and other health technologies. London: Office of Health Economics, 1996
3. 3. Commonwealth Department of Health, Housing and Community Services. Guidelines for the pharmaceutical industry on the preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Australian Government Publishing Service, 1992
4. 4. Department of Human Services and Health. Guidelines for the pharmaceutical industry on the preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Australian Government Publishing Service, 1995
5. 5. Ministry of Health, Ontario guidelines for the economic analysis of pharmaceuticals. Toronto (ON): Ministry of Health, 1994
6. 6. Langley PC. Pharmacoeconomics: achieving gold standards. London: Financial Times Healthcare, 1997
7. 7. Langley PC, Sullivan SD. Pharmacoeconomic evaluations: guidelines for drug purchasers. J Manage Care Pharm 1996; 2 (6): 671-7
8. 8. Langley PC, Martin RE. Guidelines for formulary submission, October 1996. Rancho Cordova (CA): Foundation Health and Integrated Pharmaceutical Services, 1996
9. 9. Langley PC, Martin RE. Managed care guidelines for the economic evaluation of pharmaceuticals. Am J Manage Care 1997; 3: 733-41
10. 10. Regence Washington Health Pharmacy Services. Guidelines for the submission of clinical and economic data supporting formulary consideration. Seattle (WA): Regence Washington Health, 1997
11. 11. Drummond MF, O'Brien B, Stoddart GL. Methods for the economic evaluation of health care programmes. 2nd ed. New York: Oxford University Press, 1997
12. 12. Feldstein PJ. Health care economics. 5th ed. Albany (NY): Delmar, 1999